Ovid Therapeutics Inc.
OVID
$2.42
$0.062.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.99M | 9.66M | -12.16M | -4.68M | -10.24M |
| Total Depreciation and Amortization | 35.00K | 17.00K | 16.00K | 99.00K | 141.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 722.00K | -20.22M | 961.00K | 1.06M | 1.12M |
| Change in Net Operating Assets | 2.33M | 134.00K | -1.69M | -1.24M | -1.30M |
| Cash from Operations | -13.90M | -10.41M | -12.87M | -4.77M | -10.28M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.95M | -72.06M | 5.05M | 12.05M | 5.10M |
| Cash from Investing | 5.95M | -72.06M | 5.05M | 12.05M | 5.10M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 86.62M | 75.18M | 15.00K | 0.00 | 13.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.37M | -- | -- | -- | -- |
| Cash from Financing | 88.98M | 75.18M | 15.00K | 0.00 | 13.00K |
| Foreign Exchange rate Adjustments | -122.00K | -167.00K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.91M | -7.46M | -7.80M | 7.28M | -5.17M |